Daily feed · SEC Form 4 filings
Significant insider purchases — Aug 28, 2018
Open-market purchases of at least $50,000 — or at least $500,000 when the buyer is a 10% owner.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2018 PForm 4/A → | Aug 27, 6:12 pm EDT | Crinetics Pharmaceuticals, Inc.CRNX | PERCEPTIVE ADVISORS LLC +2Director, 10% Owner | 707,648 | $18.87 | $13,352,902 | 2,587,953 | +37.6% | plan? |
| Aug 23, 2018 PForm 4 → | Aug 27, 5:32 pm EDT | OBALON THERAPEUTICS INCOBLN | Parters Vii L P Domain +510% Owner | 1,648,359 | $1.82 | $3,000,013 | 5,634,329 | +41.4% | plan? |
| Aug 23, 2018 PForm 4 → | Aug 27, 4:24 pm EDT | OBALON THERAPEUTICS INCOBLN | INTERWEST PARTNERS X LP +510% Owner | 1,098,901 | $1.82 | $2,000,000 | 3,552,239 | +44.8% | plan? |
| Aug 23, 2018 PForm 4 → | Aug 27, 5:48 pm EDT | Liberty Latin America Ltd.LILA | Balan NairPresident and CEO, Director | 110,000 | $18.14 | $1,995,619 | 88,195 | — | plan? |
| Aug 24, 2018 PForm 4 → | Aug 27, 4:39 pm EDT | New Age Beverages CorpNBEV | Ed BrennanDirector | 1,195,000 | $1.30 | $1,547,618 | 1,225,232 | +3,953% | plan? |
| Dec 18, 2017 PForm 4/A → | Aug 27, 2018, 4:51 pm EDT | PROSPECT CAPITAL CORPPSEC | John F BarryCHIEF EXECUTIVE OFFICER, Director, 10% Owner | 102,207 | $6.88 | $703,542 | 29,973,054 | +0.34% | plan? |
| Aug 23, 2018 PForm 4 → | Aug 27, 7:49 pm EDT | RIGEL PHARMACEUTICALS INCRIGL | Eldon C. Mayer IIIEVP & Chief Commercial Officer | 100,000 | $2.82 | $282,320 | 115,000 | +667% | plan? |
| Aug 27, 2018 PForm 4 → | Aug 27, 4:05 pm EDT | ICHOR HOLDINGS, LTD.ICHR | Jeff AndresonChief Financial Officer | 5,200 | $24.22 | $125,944 | 10,000 | +108% | plan? |
| Aug 24, 2018 PForm 4 → | Aug 28, 2:49 pm EDT | GROW CONDOS, INC.GRWC | Carl SankoDirector | 1,670,000 | $0.06 | $100,200 | 9,704,048 | +20.8% | plan? |
| Aug 23, 2018 PForm 4 → | Aug 27, 5:38 pm EDT | OBALON THERAPEUTICS INCOBLN | Kim P. KamdarDirector | 54,945 | $1.82 | $100,000 | 68,345 | +410% | plan? |
| Aug 23, 2018 PForm 4 → | Aug 27, 4:46 pm EDT | Aclaris Therapeutics, Inc.ACRS | Stephen A. TullmanDirector | 6,600 | $15.00 | $98,985 | 170,357 | +4.03% | plan? |
| Aug 23, 2018 PForm 4 → | Aug 27, 6:47 pm EDT | BioNano Genomics, IncBNGO | Christopher J TwomeyDirector | 10,000 | $6.13 | $61,250 | 10,000 | — | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.